price
NASDAQ · AVTX
Avalo Therapeutics, Inc.
Healthcare · Biotechnology
$14.60
Down-$1.01 (-6.92%)
Updated Oct 6, 2026, 10:17 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 220.35M
- P/E ratio
- -2.73
- Dividend yield
- 0.00%
- 52-week range
- $12.51 – $24.27
- Volume
- 736.84K
- Avg. volume
- 410.27K
Price performance · AVTX
AVTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
AVTX closed at $14.60 after 20 trading sessions, down 25.93% for the selected period.
- Last close
- $14.60
- Period change
- -25.93%
- Period low
- $14.60
- Period high
- $19.71
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $15.09 | $15.09 | $14.39 | $14.60 | 736.84K |
| Oct 2, 2026 | $15.05 | $15.16 | $14.3081 | $14.99 | 948.52K |
| Oct 1, 2026 | $15.24 | $15.57 | $14.78 | $14.95 | 932.39K |
| Sep 30, 2026 | $15.80 | $15.99 | $15.14 | $15.33 | 1.43M |
| Sep 29, 2026 | $15.16 | $15.67 | $14.74 | $15.58 | 1.33M |
| Sep 28, 2026 | $15.47 | $15.47 | $14.97 | $15.08 | 749.65K |
| Sep 25, 2026 | $15.75 | $15.81 | $15.00 | $15.47 | 1.43M |
| Sep 24, 2026 | $15.24 | $16.10 | $14.58 | $15.72 | 1.9M |
| Sep 23, 2026 | $16.40 | $16.49 | $15.13 | $15.30 | 1.11M |
| Sep 22, 2026 | $16.44 | $16.865 | $16.28 | $16.51 | 585.53K |
| Sep 21, 2026 | $16.57 | $16.75 | $15.92 | $16.17 | 542.68K |
| Sep 18, 2026 | $16.66 | $16.925 | $16.34 | $16.57 | 3.23M |
| Sep 17, 2026 | $17.105 | $17.19 | $16.52 | $16.69 | 691.27K |
| Sep 16, 2026 | $16.17 | $16.695 | $15.87 | $16.58 | 1.44M |
| Sep 15, 2026 | $16.13 | $16.69 | $15.39 | $16.07 | 1.1M |
| Sep 14, 2026 | $16.43 | $16.53 | $16.12 | $16.18 | 908.42K |
| Sep 11, 2026 | $17.42 | $18.135 | $16.02 | $16.12 | 2.53M |
| Sep 10, 2026 | $17.92 | $18.05 | $17.15 | $17.18 | 913.75K |
| Sep 9, 2026 | $19.47 | $19.74 | $18.035 | $18.21 | 725.72K |
| Sep 8, 2026 | $19.01 | $20.49 | $18.95 | $19.71 | 779.7K |
Latest AVTX news
The latest Smart Investors Daily articles mentioning AVTX.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…